Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.5226
-0.0044 (-0.83%)
At close: Apr 2, 2025, 4:00 PM
0.5279
+0.0053 (1.01%)
After-hours: Apr 2, 2025, 7:55 PM EDT

Oncolytics Biotech Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-31.71-27.75-24.84-26.3-22.51
Upgrade
Depreciation & Amortization
0.410.40.390.450.45
Upgrade
Loss (Gain) From Sale of Assets
0.02----
Upgrade
Stock-Based Compensation
2.722.072.383.832.56
Upgrade
Other Operating Activities
-1.94-4.93-1.680.5-2.78
Upgrade
Change in Accounts Receivable
-0.050.510.35-0.781.98
Upgrade
Change in Accounts Payable
1.22-0.081.660.18-1.37
Upgrade
Change in Other Net Operating Assets
2.371.34-1.62-0.32-0.4
Upgrade
Operating Cash Flow
-26.97-28.45-23.36-22.43-22.07
Upgrade
Capital Expenditures
-0.24-0.01-0.06-0.29-0.03
Upgrade
Investment in Securities
-20.23-20.35--
Upgrade
Investing Cash Flow
-0.2420.22-20.4-0.29-0.03
Upgrade
Long-Term Debt Repaid
-0.35-0.41-0.38-0.37-0.46
Upgrade
Net Debt Issued (Repaid)
-0.35-0.41-0.38-0.37-0.46
Upgrade
Issuance of Common Stock
7.7432.413.3534.6441.98
Upgrade
Other Financing Activities
-0.75--0.76-1.26-1.74
Upgrade
Financing Cash Flow
6.6431.9912.2133.0239.77
Upgrade
Foreign Exchange Rate Adjustments
1.6-0.521.96-0.25-0.6
Upgrade
Net Cash Flow
-18.9723.25-29.610.0417.07
Upgrade
Free Cash Flow
-27.21-28.46-23.41-22.72-22.1
Upgrade
Free Cash Flow Per Share
-0.36-0.42-0.40-0.42-0.55
Upgrade
Cash Income Tax Paid
0.180.120.050.040.01
Upgrade
Levered Free Cash Flow
-16.34-18.15-12.68-13.59-20.74
Upgrade
Unlevered Free Cash Flow
-16.34-18.15-12.68-13.59-20.74
Upgrade
Change in Net Working Capital
-2.63-0.66-1.431.197.8
Upgrade
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q